AI assistant in Moscow region medicine: over a million prescriptions have undergone automatic verification
An AI-powered digital assistant integrated into the Moscow region's healthcare system has processed over one million medical prescriptions in six months. This is a significant milestone in integrating neural networks into clinical practice, demonstrating the real potential of AI to reduce medical errors and optimize therapeutic decisions.
How the validation system works
The tool operates automatically, evaluating each prescription against 15 key parameters. These include drug compatibility, compliance of dosages with the patient's age and gender, as well as risks of overdose and exceeding recommended treatment durations. Importantly, the system is active both during in-person appointments and during telemedicine consultations where prescription renewals or adjustments are required.
The algorithm is triggered at the moment a prescription is issued and instantly cross-checks patient data against the prescribed medications, flagging potential issues before the drug reaches the patient. Regional health officials emphasize: the technology merely adds an extra layer of precision when choosing a treatment plan, but the final decision always remains with the physician.
Regional Deputy Governor Lyudmila Bolataeva notes that the tool helps select the optimal therapy option, working both in person and during remote consultations. It is not a replacement for a specialist but rather a digital assistant that handles routine checks.
AI as a trend in Russian medicine
The Moscow region is not a pioneer in this area. Similar projects are already being implemented at the federal level and in individual regions. For example, in Moscow, 200 medical AI services have been tested over six years, 67 of which are actively used in hospitals. More than 2,000 clinics from 75 regions have connected to the MosMedAI platform, providing access to radiology diagnostic algorithms based on imaging.
Yandex is also eyeing this market. In late July, the company registered Yandex Med LLC to develop medical software. Their digital assistant can already transcribe doctor-patient conversations, find relevant data in the knowledge base, and prepare a brief summary of a patient's medical history.
The use of neural networks extends beyond clinics. Recently, they were used for the first time to assemble complete genomes of bacteriophages—viruses that infect bacteria. Of the 16 samples obtained in the laboratory, all proved viable, opening new horizons for biotechnology.
My view as an analyst: The trend is obvious—AI is becoming an integral part of medical infrastructure, and the Moscow region shows how quickly such solutions can be scaled. However, the key challenge lies not in technology but in the trust of doctors and patients in algorithms. The project's success will depend on how organically AI fits into existing workflows without creating unnecessary bureaucracy.